Audit 409053

FY End
2025-09-30
Total Expended
$2.27M
Findings
11
Programs
6
Year: 2025 Accepted: 2026-08-13

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1226429 2025-004 Material Weakness Yes L
1226430 2025-005 Material Weakness Yes P
1226431 2025-005 Material Weakness Yes P
1226432 2025-005 Material Weakness Yes P
1226433 2025-006 Material Weakness Yes L
1226434 2025-006 Material Weakness Yes L
1226435 2025-006 Material Weakness Yes L
1226436 2025-006 Material Weakness Yes L
1226437 2025-006 Material Weakness Yes L
1226438 2025-006 Material Weakness Yes L
1226439 2025-006 Material Weakness Yes L

Contacts

Name Title Type
EAJHMUF6E693 Gwendolyn A Daniels Auditee
3133249717 Jay Wilde Auditor
No contacts on file

Notes to SEFA

The accompanying schedule of expenditures of federal awards includes the federal grant activity of Institute for Population Health, Inc. (the Agency) and is presented on the same basis of accounting as the financial statements. The information in this schedule is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). In addition, expenditures reported on the schedule are recognized following the federal cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowed or are limited as to reimbursement. Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in the preparation of, the basic financial statements. Because the schedule presents only a selected portion of the operations of the Agency, it is not intended to and does not present the financial position, change in net position or cash flows of the Agency.
The Agency has elected to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance.
All subsequent events related to the major programs were evaluated through June XX, 2026, the date the accompanying reports were available to be issued. No significant event was noted that required adjustment or disclosure in the report.

Finding Details

Criteria – As per the Notice of Grant Award between IPH (the Agency) and U.S Department of Health and Human Services (DHHS) and per 45 CFR Part 74, the Agency is required to submit the performance report within 90 days and should include completing the financial forms, project abstract, grant summary and performance measures. Condition and Description – During our testing for “Performance Measure Report”, submitted, we noted that out of 10 objectives selected, 1 objective was not achieved. Cause/Effect – Internal controls were not properly executed or monitored to ensure the achievement of the established objectives. As a result, the Agency did not comply with the requirement.
Criteria – As per the HRSA compliance manual, the health center requires that at least 51 percent of governing board members be patients of the health center. A patient board member must have received at least one service within the preceding 24 months that generated a health center visit, where both the service and the site were within the HRSA-approved scope of project. Condition and Description – During our testing of the composition of the governing board, we noted that only 6 of the 12 governing board members (50%) were identified as patient board members. To satisfy the Health Center Program requirement that at least 51% of governing board members be patients of the health center, a minimum of 7 of the 12 board members were required to meet the patient board member definition. Additionally, testing revealed that 3 of the 6 board members identified as patient board members did not receive at least one service within the preceding 24 months that generated a health center visit, where both the service and the site were within the HRSA-approved scope of project. As a result, these individuals did not meet the Health Center Program definition of a patient board member. Consequently, the Agency did not maintain a governing board with at least 51% patient representation as required by HRSA. Cause/Effect – The Agency has not complied with the requirements for maintaining a governing board with at least 51% patient representation and including receipt of qualifying services within the preceding 24 months
Criteria – Per the Single Audit Act, an audit submission deadline is earlier of 30 calendar days after receipt of the audit report, or nine months after the end of the audit period, as outlined in 2CFR 200.512(a). Condition and Description – The audit submission was subsequent to June 30, 2026 and was therefore a late filing. Cause and Effect – Due to additional time needed to resolve issues with revenues and receivables, the audit was unable to be completed by the June 30, 2026 deadline.